3D Global Biotech Inc. (TPEX: 6808)
Taiwan
· Delayed Price · Currency is TWD 39.20
-0.80 (-2.00%)
Dec 3, 2024, 2:21 PM CST
3D Global Biotech Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2017 |
| Revenue | 55.15 | 20.63 | 13.64 | 11.08 | 13.26 | 18.18 | Upgrade
|
| Revenue Growth (YoY) | 235.81% | 51.24% | 23.19% | -16.48% | -27.05% | 53.37% | Upgrade
|
| Cost of Revenue | 19.79 | 15.36 | 10.93 | 9.27 | 8.29 | 10.25 | Upgrade
|
| Gross Profit | 35.36 | 5.27 | 2.72 | 1.8 | 4.97 | 7.92 | Upgrade
|
| Selling, General & Admin | 31.06 | 29.53 | 29.53 | 26.41 | 19.68 | 29.71 | Upgrade
|
| Research & Development | 39.33 | 38.6 | 39.48 | 37.6 | 35.62 | - | Upgrade
|
| Operating Expenses | 70.39 | 68.13 | 69 | 64.01 | 55.3 | 44.23 | Upgrade
|
| Operating Income | -35.03 | -62.85 | -66.29 | -62.21 | -50.33 | -36.31 | Upgrade
|
| Interest Expense | -0.13 | -0.18 | -0.26 | -0.26 | -0.1 | -0.05 | Upgrade
|
| Interest & Investment Income | 2.91 | 2.24 | 1.68 | 1.35 | 1.71 | - | Upgrade
|
| Currency Exchange Gain (Loss) | 0.04 | 0.02 | -0.01 | 0 | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | 1.83 | 1.85 | 0.62 | 0.15 | 0.24 | 2.6 | Upgrade
|
| EBT Excluding Unusual Items | -30.38 | -58.92 | -64.25 | -60.97 | -48.48 | -33.75 | Upgrade
|
| Asset Writedown | - | - | -18.89 | - | - | - | Upgrade
|
| Other Unusual Items | - | - | 0.01 | - | - | - | Upgrade
|
| Pretax Income | -30.38 | -58.92 | -83.13 | -60.97 | -48.48 | -33.75 | Upgrade
|
| Income Tax Expense | -0.97 | -0.96 | -16.05 | -1.26 | -0.56 | 2.56 | Upgrade
|
| Net Income | -29.41 | -57.95 | -67.09 | -59.71 | -47.92 | -36.32 | Upgrade
|
| Net Income to Common | -29.41 | -57.95 | -67.09 | -59.71 | -47.92 | -36.32 | Upgrade
|
| Shares Outstanding (Basic) | 60 | 56 | 55 | 54 | 54 | 51 | Upgrade
|
| Shares Outstanding (Diluted) | 60 | 56 | 55 | 54 | 54 | 51 | Upgrade
|
| Shares Change (YoY) | 7.54% | 2.32% | 1.69% | 0.77% | 6.02% | 1.03% | Upgrade
|
| EPS (Basic) | -0.49 | -1.03 | -1.22 | -1.11 | -0.89 | -0.72 | Upgrade
|
| EPS (Diluted) | -0.49 | -1.03 | -1.22 | -1.11 | -0.89 | -0.72 | Upgrade
|
| Free Cash Flow | -13.66 | -32.39 | -35.33 | -38.85 | -23.26 | -17.67 | Upgrade
|
| Free Cash Flow Per Share | -0.23 | -0.58 | -0.64 | -0.72 | -0.43 | -0.35 | Upgrade
|
| Gross Margin | 64.12% | 25.56% | 19.91% | 16.28% | 37.49% | 43.59% | Upgrade
|
| Operating Margin | -63.51% | -304.62% | -485.87% | -561.71% | -379.52% | -199.73% | Upgrade
|
| Profit Margin | -53.32% | -280.87% | -491.72% | -539.10% | -361.35% | -199.79% | Upgrade
|
| Free Cash Flow Margin | -24.76% | -156.99% | -258.98% | -350.81% | -175.38% | -97.23% | Upgrade
|
| EBITDA | -18.79 | -46.49 | -47.15 | -42.46 | -30.41 | -25.02 | Upgrade
|
| EBITDA Margin | -34.07% | -225.30% | - | - | -229.35% | -137.65% | Upgrade
|
| D&A For EBITDA | 16.24 | 16.37 | 19.14 | 19.75 | 19.91 | 11.28 | Upgrade
|
| EBIT | -35.03 | -62.85 | -66.29 | -62.21 | -50.33 | -36.31 | Upgrade
|
| EBIT Margin | -63.51% | - | - | - | - | -199.73% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.